Positron emission tomography/computer tomography in guidance of extrahepatic hepatocellular carcinoma metastasis management

World Journal of Gastroenterology

Volumn 13, Issue 40, 2007, Pages 5413-5415

  Sun, Long ^a   Guan, Yong Song ^b   Pan, Wei Ming ^a   Chen, Gui Bing ^a   Luo, Zuo Ming ^a   Wu, Hua ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Extrahepatic metastasis; Fluorodeoxyglucose; Huge hepatocellular carcinoma; Omental node metastasis; Positron emission tomography computer tomography

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CASE REPORT; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; GOLD STANDARD; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER SURGERY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; METASTASIS POTENTIAL; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; TREATMENT OUTCOME;

EID: 35248882487     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i40.5413     Document Type: Article

References (16)

1. Lee SG, Hwang S, Jung JP, Lee YJ, Kim KH, Ahn CS. Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions. Br J Surg 2007; 94: 320-326
2. Verhoef C, Holman FA, Hussain SM, de Man RA, de Wilt JH, IJzermans JN. Resection of extrahepatic hepatocellular carcinoma metastasis can result in long-term survival. Acta Chir Belg 2005; 105: 533-536
3. Tomimaru Y, Sasaki Y, Yamada T, Eguchi H, Takami K, Ohigashi H, Higashiyama M, Ishikawa O, Kodama K, Imaoka S. The significance of surgical resection for pulmonary metastasis from hepatocellular carcinoma. Am J Surg 2006; 192: 46-51
4. Anderson GS, Brinkmann F, Soulen MC, Alavi A, Zhuang H. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation. Clin Nucl Med 2003; 28: 192-197
5. Chen XP, Qiu FZ, Wu ZD, Zhang BX. Hepatectomy for huge hepatocellular carcinoma in 634 cases. World J Gastroenterol 2006; 12: 4652-4655
6. Yuan YF, Li BK, Li JQ, Zhang YQ, Guo RP, Lin XJ, Li GH. Long-term prognosis after hepatic resection for huge primary iver cancer. Aizheng 2004; 23: 821-824
7. Chen XP, Qiu FZ, Wu ZD, Zhang BX. Chinese experience with hepatectomy for huge hepatocellular carcinoma. Br J Surg 2004; 91: 322-326
8. Lee SG, Hwang S, Jung JP, Lee YJ, Kim KH, Ahn CS. Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions. Br J Surg 2007; 94: 320-326
9. Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004; 350: 351-360
10. Zhao M, Wu PH, Zeng YX, Zhang FJ, Huang JH, Fan WJ, Gu YK, Zhang L, Tan ZB, Lin YE. Evaluating efficacy of transcatheter arterial chemo-embolization combined with radiofrequency ablation on patients with hepatocellular carcinoma by 18FDG-PET/CT. Aizheng 2005; 24:1118-1123
11. Liu FY, Chen JS, Changchien CR, Yeh CY, Liu SH, Ho KC, Yen TC. Utility of 2-fluoro-2-deoxy-D-glucose positron emission tomography in managing patients of colorectal cancer with unexplained carcinoembryonic antigen elevation at different levels. Dis Colon Rectum 2005; 48: 1900-1912
12. Park YA, Lee KY, Kim NK, Baik SH, Sohn SK, Cho CW. Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer. Ann Surg Oncol 2006; 13: 645-650
13. Tung-Ping Poon R, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000; 232: 10-24
14. Larson SM. Positron emission tomography-based molecular imaging in human cancer: exploring the link between hypoxia and accelerated glucose metabolism. Clin Cancer Res 2004; 10: 2203-2204
15. Larson SM, Schwartz LH. 18F-FDG PET as a candidate for "qualified biomarker": functional assessment of treatment response in oncology. J Nucl Med 2006; 47: 901-903
16. Hatano E, Ikai I, Higashi T, Teramukai S, Torizuka T, Saga T, Fujii H, Shimahara Y. Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection. World J Surg 2006; 30: 1736-1741